Testimony: Preparing for the Next Public Health Emergency: Reauthorizing the Pandemic and All-Hazards Preparedness Act
Updated PowerPoint Presentations on Health Policy Issues Relevant to Health Care Reform and a National Single-Payer Health System April 6, 2023
Letter to the OHRP and FDA Calling for Investigations into Serious Regulatory and Ethical Lapses in a Reckless Seizure Clinical Trial Funded by NIH June 8, 2021
Letter to the NIH Regarding Serious Regulatory and Ethical Lapses in a Reckless Seizure Clinical Trial Funded by the Agency June 8, 2021
Testimony Before the FDA’s Vaccines and Related Biological Products Advisory Committee Regarding the Development, Authorization, and Licensure of Vaccines to Prevent COVID-19 October 22, 2020
Letter to the Massachusetts Department of Labor Standards Providing Comments on the Agency’s Proposed COVID-19 Workplace Safety Regulations September 11, 2020
Letter to the Oregon OSHA Providing Comments on the Agency’s Draft COVID-19 Temporary Standard September 3, 2020